Clinical Trials Directory

Trials / Completed

CompletedNCT02607267

Edmonton Obesity Staging System: Post-operative Outcome and 30-day Mortality

The Importance of the Edmonton Obesity Score System in Predicting Postoperative Outcome and 30 Day Mortality After Metabolic Surgery

Status
Completed
Phase
Study type
Observational
Enrollment
534 (actual)
Sponsor
Sana Klinikum Offenbach · Academic / Other
Sex
All
Age
19 Years – 73 Years
Healthy volunteers
Not accepted

Summary

The Edmonton Obesity Staging System (EOSS) is a more comprehensive measure of obesity-related diseases and predictor of mortality than BMI or waist circumference. The aim of this study is to determine whether the EOSS is also important in predicting post - operative outcome and 30-day mortality after metabolic surgery.

Detailed description

From October 2014 to December 2015 the investigators conducted a prospective data collection on patients undergoing either laparoscopic sleeve gastrectomy (LSG) or laparoscopic Gastric Bypass (Laparoscopic Roux-en-Y-Gastric Bypass (LRYGB) and Omega-Loop-Gastric-Bypass (LOLGB)), being the first surgical treatment for severe obesity. Preoperative EOSS by Sharma et al. was applied to all patients by two different evaluators. Data collection included the following: gender, age, body mass index, waist circumference, waist to hip ratio, comorbidities, early - postoperative complications, readmission rates and 30 - day mortality. Follow-up was performed in all patients up to 1 month after surgery.

Conditions

Interventions

TypeNameDescription
OTHERLSG and LRYGBThe role of the Edmonton Obesity Staging System in predicting post-operative outcome and 30-day mortality after metabolic surgery (LSG and LRYGB)

Timeline

Start date
2014-10-01
Primary completion
2015-12-01
Completion
2016-01-01
First posted
2015-11-18
Last updated
2018-04-25

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02607267. Inclusion in this directory is not an endorsement.